2 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Systemic Amyloidosis: new trials by email Literature Review of Systemic Amyloidosis trials Research Report on Systemic Amyloidosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis Bortezomib, Pomalidomide, Dexamethasone - Systemic Amyloidosis | Phase 2 | Recruiting | Jin Lu, MD | 40 | 2024-05-06 | 2024-12-30 |
| Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01) - Systemic Amyloidosis | Phase 2 | Completed | University of Tennessee Graduate School of Medicine | 19 | 2022-12-07 | 2026-09-02 |
| 124I-p5+14 Injection Safety in Subjects With Systemic Amyloidosis 124I-p5+14 Injection - Systemic Amyloidosis | Phase 1 / Phase 2 | Completed | University of Tennessee Graduate School of Medicine | 57 | 2018-10-01 | 2022-03-25 |
Immunoglobulin Light-chain Amyloidosis (3) · Amyloidosis (1)
Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphoproliferative Disorders (3) · Metabolic Diseases (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Plasma Cell (3) · Nutritional and Metabolic Diseases (3) · Paraproteinemias (3) · Proteostasis Deficiencies (3) · Amyloidosis (2)
Bortezomib (1) · Dexamethasone (1) · Iodine-124 (1) · pomalidomide (1)
University of Tennessee Graduate School of Medicine (2) · Jin Lu, MD (1)
United States (2) · China (1)
Jin Lu (1) · Jonathan Wall, Ph.D. (1)